Skip to main content
The Journal of Physiology logoLink to The Journal of Physiology
. 2011 Nov 15;589(Pt 22):5337–5338. doi: 10.1113/jphysiol.2011.220517

PLCδ: Johnny-come-lately to ORAI and the ups and downs of calcium signalling

Mohamed Trebak 1
PMCID: PMC3240871  PMID: 22086246

Gene mapping and RNA interference screens identified the calcium (Ca2+) sensor STIM1 and the Ca2+ channel Orai1 as central components of store-operated Ca2+ entry (SOCE) and its corresponding Ca2+ release-activated Ca2+ current (ICRAC) in leukocytes and HEK293 cells (for reviews see Vig & Kinet, 2007; Potier & Trebak, 2008; Hogan et al. 2010). SOCE is activated physiologically through receptor-mediated production of inositol 1,4,5-trisphosphate (IP3) and subsequent IP3-induced store depletion. A quite natural inclination is to expect Orai1 homologues, Orai2 and Orai3, to fulfill a similar role by mediating SOCE and ICRAC in different mammalian tissues and cell types. While a general consensus among investigators is that Orai2 and Orai3 mediate SOCE and ICRAC in overexpression systems when co-expressed with STIM1, the situation in native systems is less clear. A large number of mammalian cell types and tissues studied to date exclusively signal through Orai1 in response to Ca2+ store depletion despite concomitant expression of Orai2 and Orai3 proteins in these systems. So far, the exception to this rule are two reported instances where Orai2 and Orai3 mediate native SOCE and ICRAC under quite unusual circumstances: Orai2 supports SOCE in T cells from Orai1−/− mice (Gwack et al. 2008; Vig et al. 2008) and a subset of breast epithelial cancer cell lines that expresses the oestrogen receptor uses Orai3 as its SOCE channel (Motiani et al. 2010). An attractive possibility would entail that under native conditions Orai isoforms form diverse groups of homomultimeric and heteromultimeric receptor-activated channels, some of which activated by alternative store-independent means, including mechanisms involving second messengers, reactive oxygen and nitrogen species and lipid metabolites. A large number of molecularly distinct store-operated and store-independent Orai channels would serve to enhance the diversity of Ca2+ selective conductances for the purpose of selective cell signalling in response to different membrane receptors and different strengths of agonist stimulation. Viewed from this angle, it is thus not surprising that the Ca2+ selective store-independent arachidonate-regulated Ca2+ (ARC) channel turned out to be regulated by STIM1 and encoded by heteromultimers of Orai1 and Orai3 (Shuttleworth, 2009). IARC is likely to end up representing the archetypical store-independent current for novel native Orai-mediated store-independent currents that future research might uncover.

Mechanisms of Ca2+ oscillations are diverse and vary between excitable and non-excitable cells. Depending on the cell type considered, Ca2+ oscillations may be entirely due to oscillatory responses of plasma membrane channels, entirely to oscillations of Ca2+ release channels, or to a combination of both. The mechanisms regulating Ca2+ oscillations in response to stimulation of membrane receptors that couple to IP3 production remain incompletely understood. Such intracellular Ca2+ oscillations arise in response to low physiological concentrations of agonists. Proposed models for regenerative Ca2+ oscillations in response to receptor stimulation include either spiking of cellular IP3 levels (Woods et al. 1987) or fluctuations of cytosolic Ca2+ concentrations while cellular IP3 levels remain constant (Berridge, 1990) (for review see Putney & Bird, 2008). Although these Ca2+ oscillations often result from cycles of discharge and re-uptake of Ca2+ by intracellular stores, in most cases Ca2+ influx across plasma membrane channels is essential for maintenance of Ca2+ oscillations; in the absence of extracellular Ca2+, Ca2+ spiking will cease after a few cycles (Dupont et al. 2011). Ca2+ oscillations are proposed to provide digitally encoded signals in terms of amplitude and frequency that ensure efficiency and specificity of coupling to downstream effectors (Dupont et al. 2011). In a recent issue of The Journal of Physiology, Thompson & Shuttleworth (2011) provide significant new insights on a novel means by which the frequency of Ca2+ oscillations is modulated by the rate of Ca2+ influx through ARC channels in a HEK293 cell line stably expressing the muscarinic m3 receptor (m3-HEK cells). Using the rate of decay of the PIP2-dependent inwardly rectifying K+ channel (Kir2.1) as a read out for PIP2 depletion, Thompson and Shuttleworth show that the Ca2+ entry signal through IARC causes PIP2 decay. Significantly, they show that this ability to deplete PIP2 is specific to IARC and could not be achieved under maximal activation of ICRAC, suggesting that global increases in cytosolic Ca2+ have no effect on PIP2 depletion and that this effect is mediated specifically by highly localized Ca2+ signals through IARC. In fact, they show that transfection into cells of an Orai3 dominant negative construct (E81Q; shown previously to abrogate IARC activity with no effect on ICRAC; (Mignen et al. 2008) essentially inhibited the PIP2 depletion seen in response to IARC activation. How does Ca2+ entry through IARC specifically couple to PIP2 decay to modulate the frequency of Ca2+ oscillations? Thompson and Shuttleworth show that an isoform of the archetypical phospholipase C (PLC), the Ca2+-activated PLCδ3, is involved in sensing Ca2+ entry through IARC. Incorporation of high concentrations of IP3 (50 μm, known to inhibit PLCδ activity) in the patch pipette, specific RNAi against PLCδ3 and transfection of a catalytically impaired form of PLCδ3 (H352A) all inhibit IARC-mediated decay of Kir2.1 activity. Finally, transfection of the E81Q-Orai3 or H352A-PLCδ3 dominant negative constructs into m3-HEK cells significantly reduced the frequency of Ca2+ oscillations in response to very low concentrations of agonist (0.5 μm carbachol) by one-third.

Putney and Bird have proposed that ICRAC is the Ca2+ influx channel necessary to maintain Ca2+ oscillations and as of this writing the relative contributions of IARC and ICRAC to agonist-mediated Ca2+ oscillations in HEK293 cells is still a matter of debate (Shuttleworth, 2004; Putney & Bird, 2008). One reason for the discrepancy between the results of these two groups might lie in the cell type used; while Thompson and Shuttleworth use m3-HEK cells, Putney and Bird have conducted their studies in a HEK293 cell line with endogenous levels of muscarinic receptors. Alternatively, both IARC and ICRAC might contribute, to varying degrees, to the maintenance of Ca2+ oscillations in the same cell and could compensate for each other when the function of one conductance is abrogated. In fact, Bird and Putney showed that ectopic expression of the non-selective transient receptor potential canonical 3 (TRPC3) channel can also support Ca2+ oscillations in HEK293 cells (Bird & Putney, 2005). In the same study, Bird and Putney used a protocol where HEK293 cells are incubated with 1 mm Gd3+ to block both Ca2+ entry and Ca2+ extrusion (called lanthanide insulation) and showed that under these conditions Ca2+ oscillations are maintained in the absence of extracellular Ca2+ (Bird & Putney, 2005). Although not statistically significant under the experimental conditions used, an intriguing finding in this study is the decrease in the frequency of Ca2+ oscillations during lanthanide insulation by approximately 30–40% that could be explained by a role of Ca2+ influx through IARC in regulating the frequency of Ca2+ oscillations. Likewise, the molecular interventions used by Thompson and Shuttleworth did not completely prevent oscillations, allowing for a significant contribution of ICRAC in their system.

The study of Thompson and Shuttleworth provides insights into how a discrete and spatially restricted Ca2+ signal can couple to an IP3-producing enzyme to modulate oscillatory Ca2+ signals. Because IARC does not produce enough IP3 to cause any perceptible Ca2+ release, Thompson and Shuttleworth propose that PLCδ acts as a signal amplifier rather than an initiator, a proposition that is in line with earlier clues deduced from the unique biochemical features of PLCδ (Rebecchi & Pentyala, 2000). The work of Thompson and Shuttleworth prompts a number of important questions: what is the nature of the specific coupling between PLCδ and IARC? What mediators, scaffolding proteins or membrane lipids, if any, are involved in this coupling, since the authors failed to detect direct interactions between STIM1, Orai1, Orai3 and PLCδ using co-immunoprecipitations and bimolecular fluorescence complementation? Are there other downstream effectors that are targeted specifically by IARC-generated Ca2+ microdomains, which would couple to transcription of specific IARC-associated genes? Does Ca2+ influx through IARC control a specific set of cell functions, distinct from those mediated by ICRAC? Earlier work has proposed that subcellular Ca2+ influx through CRAC channels can couple to specific isoforms of adenylate cyclase to modulate spatially restricted cAMP-dependent signalling (Willoughby & Cooper, 2007), and more recent findings suggest that the specificity of the information conveyed by CRAC-mediated Ca2+ oscillations in RBL mast cells is encoded within the Ca2+ influx site during the Ca2+ spikes; the coupling of Ca2+ oscillations to c-fos gene expression is lost when Ca2+ oscillations are stimulated under lanthanide insulation (Parekh, 2011). The study by Thompson and Shuttleworth introduces PLCδ as another player in the game of Ca2+ oscillations and provides the first example of a protein specifically activated by IARC-generated Ca2+ signals. Future insights into the transcriptional programmes and cell functions specifically controlled by IARC-mediated Ca2+ signals will likely generate novel means for specific control of physiological and pathophysiological functions during disease.

Acknowledgments

Research in the author's laboratory is supported by National Institutes of Health (NIH) grant 5R01HL097111. There is no conflict of interests to declare.

References

  1. Berridge MJ. J Biol Chem. 1990;265:9583–9586. [PubMed] [Google Scholar]
  2. Bird GS, Putney JW., Jr J Physiol. 2005;562:697–706. doi: 10.1113/jphysiol.2004.077289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dupont G, Combettes L, Bird GS, Putney JW. Cold Spring Harb Perspect Biol. 2011;3:pii: a004226. doi: 10.1101/cshperspect.a004226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gwack Y, Srikanth S, Oh-Hora M, Hogan PG, Lamperti ED, Yamashita M, Gelinas C, Neems DS, Sasaki Y, Feske S, Prakriya M, Rajewsky K, Rao A. Mol Cell Biol. 2008;28:5209–5222. doi: 10.1128/MCB.00360-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hogan PG, Lewis RS, Rao A. Annu Rev Immunol. 2010;28:491–533. doi: 10.1146/annurev.immunol.021908.132550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Mignen O, Thompson JL, Shuttleworth TJ. J Physiol. 2008;586:185–195. doi: 10.1113/jphysiol.2007.146258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Motiani RK, Abdullaev IF, Trebak M. J Biol Chem. 2010;285:19173–19183. doi: 10.1074/jbc.M110.102582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Parekh AB. Trends Biochem Sci. 2011;36:78–87. doi: 10.1016/j.tibs.2010.07.013. [DOI] [PubMed] [Google Scholar]
  9. Potier M, Trebak M. Pflugers Arch. 2008;457:405–415. doi: 10.1007/s00424-008-0533-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Putney JW, Bird GS. J Physiol. 2008;586:3055–3059. doi: 10.1113/jphysiol.2008.153221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Rebecchi MJ, Pentyala SN. Physiol Rev. 2000;80:1291–1335. doi: 10.1152/physrev.2000.80.4.1291. [DOI] [PubMed] [Google Scholar]
  12. Shuttleworth TJ. Sci STKE. 2004;2004:pe40. doi: 10.1126/stke.2432004pe40. [DOI] [PubMed] [Google Scholar]
  13. Shuttleworth TJ. Cell Calcium. 2009;45:602–610. doi: 10.1016/j.ceca.2009.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Thompson JL, Shuttleworth TJ. J Physiol. 2011;589:5057–5069. doi: 10.1113/jphysiol.2011.214437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Vig M, DeHaven WI, Bird GS, Billingsley JM, Wang H, Rao PE, Hutchings AB, Jouvin MH, Putney JW, Kinet JP. Nat Immunol. 2008;9:89–96. doi: 10.1038/ni1550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Vig M, Kinet JP. Cell Calcium. 2007;42:157–162. doi: 10.1016/j.ceca.2007.03.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Willoughby D, Cooper DM. Physiol Rev. 2007;87:965–1010. doi: 10.1152/physrev.00049.2006. [DOI] [PubMed] [Google Scholar]
  18. Woods NM, Cuthbertson KS, Cobbold PH. Cell Calcium. 1987;8:79–100. doi: 10.1016/0143-4160(87)90038-8. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Physiology are provided here courtesy of The Physiological Society

RESOURCES